| Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer D de Miguel-Perez, A Russo, O Arrieta, M Ak, F Barron, M Gunasekaran, ... Journal of Experimental & Clinical Cancer Research 41 (1), 186, 2022 | 50 | 2022 |
| Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers RR Colen, C Rolfo, M Ak, M Ayoub, S Ahmed, N Elshafeey, P Mamindla, ... Journal for immunotherapy of cancer 9 (4), 2021 | 41 | 2021 |
| MRI-based radiomics and radiogenomics in the management of low-grade gliomas: evaluating the evidence for a paradigm shift A Habib, N Jovanovich, M Hoppe, M Ak, P Mamindla, R R. Colen, PO Zinn Journal of Clinical Medicine 10 (7), 1411, 2021 | 29 | 2021 |
| Phytochemical screening and in silico studies of flavonoids from Chlorella pyrenoidosa R Yadavalli, JR Peasari, P Mamindla, S Mounika, J Ganugapati Informatics in Medicine Unlocked 10, 89-99, 2018 | 28 | 2018 |
| Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients M Pease, ZC Gersey, M Ak, A Elakkad, A Kotrotsou, S Zenkin, ... Journal of neuro-oncology 160 (1), 253-263, 2022 | 8 | 2022 |
| A new method for discovering EMAST sequences in animal models of cancer N Bhaskaran, J Luu, ST Kelley, MW Khan, P Mamindla, KL McGuire Scientific Reports 8 (1), 13764, 2018 | 2 | 2018 |
| Author response to Cunha et al RR Colen, C Rolfo, M Ak, M Ayoub, S Ahmed, N Elshafeey, P Mamindla, ... Journal for immunotherapy of cancer 9 (7), 2021 | 1 | 2021 |
| Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC D de Miguel‑Perez, M Ak, P Mamindla, A Russo, S Zenkin, N Ak, ... Journal of Experimental & Clinical Cancer Research 43 (1), 81, 2024 | | 2024 |
| Radiogenomics and Radiomics of Skull Base Chordoma: Machine Learning-Based Classification of Genetic Signatures and Clinical Outcomes by Multiparametric MRI ZC Gersey, S Zenkin, T Plute, AK Murat, P Mamindla, V Peddagangireddy, ... Journal of Neurological Surgery Part B: Skull Base 85 (S 01), S345, 2024 | | 2024 |
| Associating T1-Weighted and T2-Weighted Magnetic Resonance Imaging Radiomic Signatures With Preoperative Symptom Severity in Patients With Cervical Spondylotic Myelopathy N Alan, S Zenkin, RS Lavadi, AD Legarreta, JS Hudson, DP Fields, ... World Neurosurgery, 2024 | | 2024 |
| Associating T1-weighted and T2-weighted MRI Radiomic Signatures with Preoperative Symptom Severity in Patients with Cervical Spondylotic Myelopathy. N Alan, S Zenkin, RS Lavadi, AD Legarreta, JS Hudson, DP Fields 2nd, ... World Neurosurgery, S1878-8750 (24) 00085, 2024 | | 2024 |
| Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma A Tompkins, ZN Gray, RE Dadey, S Zenkin, N Batavani, S Newman, ... medRxiv, 2024.04. 26.24306411, 2024 | | 2024 |
| Author Correction: Characterization of neural mechanotransduction response in human traumatic brain injury organoid model SM Beltrán, J Bobo, A Habib, CV Kodavali, L Edwards, P Mamindla, ... Scientific Reports 14, 2024 | | 2024 |
| Extracellular Vesicles and Radiomics Predict Durable Response to Immune-Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer D Perez, P Mamindla, A Russo, M Ak, M Gunasekaran, M Del Re, ... JOURNAL OF THORACIC ONCOLOGY 18 (11), S236-S236, 2023 | | 2023 |
| P1. 21-06 Extracellular Vesicles and Radiomics Predict Durable Response to Immune-Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer D de Miguel Perez, P Mamindla, A Russo, M Ak, M Gunasekaran, ... Journal of Thoracic Oncology 18 (11), S236, 2023 | | 2023 |
| Characterization of neural mechanotransduction response in human traumatic brain injury organoid model SM Beltrán, J Bobo, A Habib, CV Kodavali, L Edwards, P Mamindla, ... Scientific reports 13 (1), 13536, 2023 | | 2023 |
| A radiomic-based predictive model of lung adenocarcinoma brain metastases and molecular subtypes. X Wu, MA Velez, M Ak, N Tahon, P Mamindla, V Peddagangireddy, ... Journal of Clinical Oncology 41 (16_suppl), 2014-2014, 2023 | | 2023 |
| Combined extracellular vesicle PD-L1 and radiomics as predictors of response in patients with advanced lung cancer undergoing immunotherapy M Ak, DDM Perez, P Mamindla, A Russo, V Peddagangireddy, ME Er, ... Cancer Research 83 (7_Supplement), 4329-4329, 2023 | | 2023 |
| Robustness of Randomized Control Trials Supporting Current Neurosurgery Guidelines POZ N U Farrukh Hameed, Xiaoran Zhang, Omar Sajjad, Sam Sathyamurthi ... Neurosurgery, 2023 | | 2023 |
| TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype in vitro SK Singh, Y Wang, A Habib, M Priyadarshini, CV Kodavali, A Chen, W Ma, ... Frontiers in Oncology 13, 2023 | | 2023 |
